Insider Transactions Reported by 10 Insiders of ADIAL PHARMACEUTICALS, INC.

Symbol
ADIL on Nasdaq
Location
Charlottesville, VA

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

ADIAL PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William B. Stilley III Director $530,200 23 May 2023
Joseph Truluck Chief Financial Officer $111,411 25 Mar 2024
Dr. Bankole Johnson Director 23 May 2023
James W. Newman Jr. Director 29 May 2025
Tony Goodman Chief Operating Officer, Director 29 May 2025
J. Kermit Anderson Director 29 May 2025
Robertson H. Gilliland Director 29 May 2025
Vinay Shah Chief Financial Officer 29 May 2025
Kevin Schuyler Director 29 May 2025
Cary J. Claiborne Chief Executive Officer, Director 29 May 2025

Recent Insider Transactions by Companies or Individuals for ADIAL PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.